5-Methyl-3,4-diffenyl
Rhif CAS:37928-17-9
[Cyfystyron]
3,4-Diffenyl-5-methylisoxazole
4-diphenyl-(Parecoxib sodiuM canolradd)
5-Methyl-3
5-Methyl-3,4-diffenyl-1,2-oxazole
5-Methyl-3,4-diphenylisoxazole
Rhif CBN: CB52604537
Fformiwla Foleciwlaidd: C16H13RHIF
Pwysau Moleciwlaidd: 235.28
Rhif MDL:MFCD18449672
Ffeil MOL:37928-17-9.mol
Pwynt toddi 96.0 i 100.0 gradd
Pwynt berwi 340.1±21.0 gradd (Rhagweld)
Dwysedd 1.108±0.06 g/cm3(Rhagweld)
Tymheredd storio. Wedi'i selio mewn sych, tymheredd ystafell
Clorofform hydoddedd (ychydig), dmso (ychydig), methanol (ychydig)
Pka {{0}}.53±0.50(rhagweld)
Ffurfio solet
Lliw gwyn i all-gwyn
InChIKey ZXIRUKJWLADSJS-UHFFFAOYSA-N
[Defnyddiau]
5-Methyl-3,4-diphenylisoxazole yw synthesis Canolradd allweddol Parecoxib Sodiwm (Parecoxib Sodiwm).Parecoxib Sodiwm yw gan Pfizer yr Unol Daleithiau Atalydd cox 2 o ymchwil a datblygiad cwmni, a restrir yn yr Undeb Ewropeaidd yn 2002, enw masnach Dynastat, yn cael ei ddefnyddio ar gyfer The therapi tymor byr o boen ar ôl llawdriniaeth.
Tagiau poblogaidd: 5-methyl-3,4-diphenyl, Tsieina, gwneuthurwyr, cyflenwyr, ffatri, cyfanwerthu, arferiad
![N-[4-Cyano-3-(trifluoromethyl)ffenyl]methacrylamid Epocsi](/uploads/24039/small/n-4-cyano-3-trifluoromethyl-phenyl68a8a.png)
![N-[2-[(2-Aminoethyl) amino]ethyl]-O-(phenylmethyl)-L-serine](/uploads/24039/small/n-2-2-aminoethyl-amino-ethyl-o-phenylmethyl-l0757c.png)
![N-[5-(Diphenyl-phosphinoylmethyl)-4-(4-fflworo-ffenyl)-6-isopropyl-pyrimidin-2-yl]-N-methyl-methanesulfonamide](/uploads/24039/small/n-5-diphenyl-phosphinoylmethyl-4-4-fluoroda08c.png)
![5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-7-carbonitrile -1H-indole (2R,3R)-2,3-dihydroxybutanediate](/uploads/24039/small/5-2r-2-aminopropyl-1-3-benzoyloxy-propyl-2-3870b6.png)
